First generic copy of Roche’s Tamiflu hits US market
December 12, 2016Sales and Marketing Alvogen, Roche, Tamiflu
Drugmaker Alvogen has released the first generic version of Roche’s flu medication Tamiflu (oseltamivir) in the US, where it expects …
AZ and Lilly come together to battle Alzheimer’s
December 9, 2016Research and Development, Sales and Marketing AZ, lilly
Pharma titans Eli Lilly and AstraZeneca have announced they are to join forces to co-develop a potential Alzheimer’s treatment, currently …
Top Ten most popular articles on Pharmafile.com this week
December 9, 2016Medical Communications top ten
Christmas is drawing ever closer, but that doesn’t mean the industry is slowing down. This week, features from the latest …
AZ to terminate 700 US jobs
December 9, 2016Manufacturing and Production, Medical Communications AstraZeneca, job cuts
AstraZeneca has revealed that it plans to cut 700 positions across the US by 10 February 2017, including 120 positions …
Top Pharmaceutical Markets 2016: China
December 9, 2016Business Services, Manufacturing and Production, Medical Communications, Sales and Marketing China, market analysis
Originally featured in Pharmafile Autumn 2016, a report from the United States International Trade Administration sheds light on the Chinese …
Flickering LEDs could light the way for new Alzheimer’s treatment
December 8, 2016Medical Communications, Research and Development Alzheimer's, Cognito therapeutics, mice
Research to find a potential new treatment for Alzheimer’s was hit a blow late last month, as Eli Lilly discontinued …
European thumbs up for Abbvie leukaemia drug
December 8, 2016Medical Communications, Sales and Marketing AbbVie, Venclyxto
Abbvie has confirmed its Venclyxto (venetoclax) has been granted marketing authorisation by the European Commission (EC) as a monotherapy for …
Novartis’ drug doubly effective as chemotherapy for treating lung cancer
December 8, 2016NSCLC, Novartis, chemotherapy
Novartis have released that its drug, Zykadia, in Phase III trials, was twice as effective at slowing progression in advanced …
Teva embroiled in internal bribery investigation
December 8, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva, bribery
Israeli pharmaceutical firm Teva has confirmed it is embroiled in an ongoing internal investigation into allegations of bribery, after the …
Mylan to restructure and slash around 10% of workforce
December 8, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mylan, epipen, job losses
Mylan has submitted a regulatory filing to the Securities and Exchange Commission to announce that it would be potentially cutting …
BMS shares promising Opdivo/Yervoy data for advanced bladder cancer
December 8, 2016Research and Development BMS, Yervoy, opdivo
BMS has revealed new efficacy data on the combination of its immunotherapies Opdivo (nivolumab) and Yervoy (ipilimumab) for the treatment …
New Alzheimer’s research edges closer to treatment & prevention
December 7, 2016Research and Development Alzheimer's
A new study has shed light on the possible prevention and treatment of Alzheimer’s disease thanks to findings centred on …
AbbVie links up with Johns Hopkins University in cancer research
December 7, 2016Medical Communications
AbbVie has announced that it has agreed a five-year collaboration agreement with Johns Hopkins University. The aim of the collaboration …
AstraZeneca’s Lisa Anson appointed president of ABPI
December 7, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Lisa Anson, current president of AstraZeneca UK & Ireland, has been appointed to the position of president of ABPI. Lisa …
Janssen reveals positive results from longest follow-up of Imbruvica
December 7, 2016Research and Development AbbVie, Cilag, Janssen, Pharmacyclics, imbruvica
Janssen used the 5th Annual American Society of Hematoly Meeting and Exposition to reveal that a five-year study of Imbruvica …
Novo pledges single-digit cap on drug price hikes
December 7, 2016Medical Communications, Research and Development, Sales and Marketing Jakob Riis, Novo Nordisk
Novo Nordisk US chief Jakob Riis (pictured) has announced the insulin giant’s commitment to limit its price increases to single-digit …
Pfizer slapped with record £84.2 million fine for 2,600% price increase
December 7, 2016Medical Communications, Research and Development CMA, Flynn Pharma, Pfizer, fine
Pfizer has been hit with a record fine by The Competition and Markets Authority for the increase in the price …
AZ lung cancer drug cuts disease progression by 70%
December 7, 2016Research and Development AstraZeneca, Tagrisso
AstraZeneca is touting its cancer drug Tagrisso (osimertinib) as a potential new standard of care for epidermal growth factor receptor …
Veeva releases key details from European Life Sciences Survey
December 6, 2016veeva
Veeva, which held its European Life Sciences Summit last week, has announced some of the key findings from its European …
Shire given permission for $400 million biologics manufacturing facility
December 6, 2016Manufacturing and Production, Research and Development Co Meat, Ireland, Shire
Shire has received planning permission for a new state-of-the-art biologics manufacturing facility in Co Meath, Ireland. The plant will be …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
